Literature DB >> 1545360

Autoxidation of tetrazepam in tablets: prediction of degradation impurities from the oxidative behavior in solution.

G Boccardi1, C Deleuze, M Gachon, G Palmisano, J P Vergnaud.   

Abstract

The major route of degradation of tetrazepam (1) is oxidation to 7-chloro-5-(3-keto-cyclohexen-1-yl)-1,3-dihydro-1-methyl-2H-1, 4-benzodiazepin-2-one (3) via the stable 7-chloro-5-(3-hydroperoxy-cyclohexen-1-yl)-1,3-dihydro-1-methyl-2H -1, 4 benzodiazepin-2-one (2). Minor degradation products are 7-chloro-5-(1,2-epoxycyclohexan-1-yl)-1,3-dihydro-1-methyl-2H-1, 4-benzodiazepin-2-one (5) and 7-chloro-1,3-dihydro-1-methyl-2H-1, 4-benzodiazepin-2,5-dione (4), resulting from cleavage of the C-C bond between the cyclohexene ring and the benzodiazepine ring. After 48 h, AIBN (2,2'-azobis[2-methyl-propanenitrile]) in acetonitrile at 40 degrees C produced qualitatively the same impurities as those observed in the stability study of tablets of 1. Other stress tests (thermal stress at 80 degrees C, heavy metal oxidation, hydrogen peroxide, acid-catalyzed oxidation) caused qualitatively different profiles of degradation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1545360     DOI: 10.1002/jps.2600810216

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Predicting drug substances autoxidation.

Authors:  P Lienard; J Gavartin; G Boccardi; M Meunier
Journal:  Pharm Res       Date:  2014-08-13       Impact factor: 4.200

2.  Medicolegal aspects of tetrazepam metabolism.

Authors:  Marion Pavlic; Kathrin Libiseller; Petra Grubwieser; Heinrich Schubert; Walter Rabl
Journal:  Int J Legal Med       Date:  2006-10-05       Impact factor: 2.791

Review 3.  Oxidation of Drugs during Drug Product Development: Problems and Solutions.

Authors:  Alen Gabrič; Žiga Hodnik; Stane Pajk
Journal:  Pharmaceutics       Date:  2022-01-29       Impact factor: 6.321

4.  Assessment of Diverse Solid-State Accelerated Autoxidation Methods for Droperidol.

Authors:  Jayant Iyer; Isha Saraf; Andrew Ray; Michael Brunsteiner; Amrit Paudel
Journal:  Pharmaceutics       Date:  2022-05-24       Impact factor: 6.525

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.